Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eaton Laboratories was a significant American pharmaceutical firm, originally established as the professional products division of the Norwich Pharmacal Company in 1945. The company gained prominence for its development of nitrofuran chemistry, leading to the creation of widely used anti-infectives like Furadantin and Macrodantin. It was also responsible for the commercialization of the muscle relaxant Dantrium and the well-known gastrointestinal treatment Pepto-Bismol. In 1982, the company, then known as Norwich Eaton, was acquired by Procter & Gamble, marking its transition into a major consumer health and pharmaceutical division. Throughout its history, Eaton was recognized for its focus on primary care and specialty therapeutics, particularly in infectious disease and gastroenterology. Its legacy continues through its products, many of which remain standard treatments in their respective fields today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eaton Laboratories.